Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Bioanalytical SystemsAuxly Cannabis GroupEloxx PharmaceuticalsPieris PharmaceuticalsCleveland BioLabs
SymbolNASDAQ:BASIOTCMKTS:CBWTFNASDAQ:ELOXNASDAQ:PIRSNASDAQ:CBLI
Price Information
Current Price$16.44$0.30$2.54$2.12$5.31
52 Week RangeBuyBuyBuyBuyN/A
MarketRank™
Overall Score1.21.41.41.40.6
Analysis Score1.53.53.33.50.0
Community Score2.33.02.92.63.2
Dividend Score0.00.00.00.00.0
Ownership Score1.70.00.00.80.0
Earnings & Valuation Score0.60.60.60.00.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyN/A
Consensus Price Target$17.00$0.40$6.50$9.00N/A
% Upside from Price Target3.41% upside35.59% upside155.91% upside324.53% upsideN/A
Trade Information
Market Cap$250.45 million$204.10 million$102.15 million$126.60 million$82.14 million
Beta1.920.612.571.40.61
Average Volume122,9252,115,13394,774522,610369,060
Sales & Book Value
Annual Revenue$60.47 million$6.29 millionN/A$46.28 million$1.11 million
Price / Sales3.0332.45N/A2.7474.00
Cashflow$0.03 per shareN/AN/AN/AN/A
Price / Cash558.40N/AN/AN/AN/A
Book Value$0.69 per share$0.31 per share$0.91 per share$0.93 per share$0.09 per share
Price / Book23.830.95N/A2.2859.00
Profitability
Net Income$-4,680,000.00$-77,300,000.00$-50,870,000.00$-25,470,000.00$-2,650,000.00
EPS($0.35)N/A($1.34)($0.56)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E Ratio411.00N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-7.75%-332.96%N/A-59.11%-382.26%
Return on Equity (ROE)-42.74%-47.37%-163.87%-55.20%-123.97%
Return on Assets (ROA)-6.38%-28.34%-89.65%-21.21%-86.26%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio2.49%0.53%0.52%N/AN/A
Current Ratio0.48%1.82%3.23%4.50%6.66%
Quick Ratio0.46%0.91%3.23%4.50%6.66%
Ownership Information
Institutional Ownership Percentage10.62%0.01%21.49%57.46%2.59%
Insider Ownership Percentage11.46%N/A33.40%6.59%1.03%
Miscellaneous
Employees397N/A291142
Shares Outstanding11.13 million691.86 million40.22 million59.72 million15.47 million
Next Earnings Date5/13/2021 (Estimated)6/7/2021 (Estimated)5/6/2021 (Estimated)5/10/2021 (Estimated)5/21/2021 (Estimated)
OptionableNot OptionableNot OptionableOptionableOptionableNot Optionable
SourceHeadline
Cleveland BioLabs, Inc. (NASDAQ:CBLI) Sees Significant Growth in Short InterestCleveland BioLabs, Inc. (NASDAQ:CBLI) Sees Significant Growth in Short Interest
americanbankingnews.com - April 17 at 12:20 PM
Cleveland BioLabs, Inc: Genome Protection Announces Publication of the Next Generation Deimmunized TLR5 Agonist, GP532Cleveland BioLabs, Inc: Genome Protection Announces Publication of the Next Generation Deimmunized TLR5 Agonist, GP532
finanznachrichten.de - April 16 at 11:38 PM
Cleveland BioLabs (NASDAQ:CBLI) Stock Passes Above 200 Day Moving Average of $4.22Cleveland BioLabs (NASDAQ:CBLI) Stock Passes Above 200 Day Moving Average of $4.22
americanbankingnews.com - April 16 at 12:39 AM
Genome Protection Announces Publication of the Next Generation Deimmunized TLR5 Agonist, GP532Genome Protection Announces Publication of the Next Generation Deimmunized TLR5 Agonist, GP532
finance.yahoo.com - April 14 at 11:02 AM
SHAREHOLDER ALERT: WeissLaw LLP Reminds MDCA, PTVCA, CBLI, and WIFI Shareholders About Its Ongoing InvestigationsSHAREHOLDER ALERT: WeissLaw LLP Reminds MDCA, PTVCA, CBLI, and WIFI Shareholders About Its Ongoing Investigations
finance.yahoo.com - April 9 at 6:38 PM
Cleveland BioLabs (NASDAQ:CBLI) Stock Passes Above 200-Day Moving Average of $4.02Cleveland BioLabs (NASDAQ:CBLI) Stock Passes Above 200-Day Moving Average of $4.02
americanbankingnews.com - April 6 at 1:36 AM
Reviewing Eloxx Pharmaceuticals (NASDAQ:ELOX) and Cleveland BioLabs (NASDAQ:CBLI)Reviewing Eloxx Pharmaceuticals (NASDAQ:ELOX) and Cleveland BioLabs (NASDAQ:CBLI)
americanbankingnews.com - April 6 at 12:12 AM
Cleveland BioLabs, Inc. (NASDAQ:CBLI) Short Interest Up 111.7% in MarchCleveland BioLabs, Inc. (NASDAQ:CBLI) Short Interest Up 111.7% in March
americanbankingnews.com - March 29 at 2:37 PM
SHAREHOLDER ALERT: WeissLaw LLP Reminds TLRY, CBLI, AKER and OBLN Shareholders About Its Ongoing InvestigationsSHAREHOLDER ALERT: WeissLaw LLP Reminds TLRY, CBLI, AKER and OBLN Shareholders About Its Ongoing Investigations
finance.yahoo.com - March 19 at 5:12 PM
Fort Collins’ soon-to-be newest public company looks to use opioid treatments to fight COVID, cancerFort Collins’ soon-to-be newest public company looks to use opioid treatments to fight COVID, cancer
bizwest.com - March 3 at 6:48 PM
Cleveland BioLabs, Inc. Announces Closing of $14 Million Registered Direct Offering of Common StockCleveland BioLabs, Inc. Announces Closing of $14 Million Registered Direct Offering of Common Stock
finance.yahoo.com - February 23 at 7:53 PM
Cleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common StockCleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common Stock
finance.yahoo.com - February 19 at 5:35 PM
Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 for Proposed Merger with Cytocom Inc.Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 for Proposed Merger with Cytocom Inc.
finance.yahoo.com - February 17 at 5:32 PM
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of CBLI, NEBC, THCB,SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of CBLI, NEBC, THCB,
apnews.com - February 16 at 9:13 PM
ALERT: Halper Sadeh LLP Investigates CPAH, CBLI, QEP, SNCA; Shareholders Are Encouraged to Contact the FirmALERT: Halper Sadeh LLP Investigates CPAH, CBLI, QEP, SNCA; Shareholders Are Encouraged to Contact the Firm
finance.yahoo.com - January 5 at 9:36 AM
Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021"Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021"
finance.yahoo.com - December 22 at 8:59 AM
Cleveland Biolabs Inc Stock , CBLICleveland Biolabs Inc Stock , CBLI
markets.businessinsider.com - December 19 at 10:40 PM
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm – PE, CEIX, CBLIALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm – PE, CEIX, CBLI
finance.yahoo.com - November 20 at 10:50 PM
Leah Brownlee—New President, General Counsel at IndagoLeah Brownlee—New President, General Counsel at Indago
ryortho.com - November 12 at 6:11 PM
ALERT: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – CXO, BSTC, CBLI, PEALERT: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – CXO, BSTC, CBLI, PE
finance.yahoo.com - November 6 at 10:02 AM
SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations - CBLI, PE, PNM, CEIXSHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations - CBLI, PE, PNM, CEIX
finance.yahoo.com - November 4 at 2:29 PM
SHAREHOLDER ALERT: WeissLaw LLP Reminds PRCP, CBLI, AMAG, and MR Shareholders About Its Ongoing InvestigationsSHAREHOLDER ALERT: WeissLaw LLP Reminds PRCP, CBLI, AMAG, and MR Shareholders About Its Ongoing Investigations
finance.yahoo.com - October 29 at 7:46 PM
INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm – CBLI, PE, PNM, CEIXINVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm – CBLI, PE, PNM, CEIX
finance.yahoo.com - October 26 at 5:19 PM
CLEVELAND BIOLABS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cleveland BioLabs, Inc. - CBLICLEVELAND BIOLABS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cleveland BioLabs, Inc. - CBLI
finance.yahoo.com - October 26 at 5:19 PM
Moore Kuehn Encourages CBLI, CEIX, PNM, and GLIBA Investors to Contact Law FirmMoore Kuehn Encourages CBLI, CEIX, PNM, and GLIBA Investors to Contact Law Firm
finance.yahoo.com - October 26 at 5:19 PM
DateCompanyBrokerageAction
3/9/2021Bioanalytical SystemsColliers SecuritiesReiterated Rating
3/10/2021Auxly Cannabis GroupCantor FitzgeraldInitiated Coverage
9/1/2020Auxly Cannabis GroupRaymond JamesReiterated Rating
7/16/2020Auxly Cannabis GroupDesjardinsInitiated Coverage
11/9/2020Eloxx PharmaceuticalsHC WainwrightReiterated Rating
6/10/2020Eloxx PharmaceuticalsCitigroupDowngrade
5/12/2020Eloxx PharmaceuticalsCanaccord GenuityReiterated Rating
5/8/2020Eloxx PharmaceuticalsJanney Montgomery ScottLower Price Target
5/8/2020Eloxx PharmaceuticalsPiper SandlerLower Price Target
8/8/2019Eloxx PharmaceuticalsSunTrust BanksLower Price Target
5/1/2018Eloxx PharmaceuticalsPiper Jaffray CompaniesInitiated Coverage
8/9/2020Pieris PharmaceuticalsWilliam BlairReiterated Rating
3/13/2020Pieris PharmaceuticalsRobert W. BairdUpgrade
5/13/2019Pieris PharmaceuticalsCowenReiterated Rating
(Data available from 4/19/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.